Frank Mattner

USPTO Granted Patents = 22 (Patent Applications = 17)

CIPO Patents = 2 (Patent Applications = 2)

EPO Patents = 13 (Patent Applications = 31)

Average Co-Inventor Count = 3.4

ph-index = 5

Forward Citations = 93(Granted Patents)

Company Filing History:

Affiris Forschungs-und Entwicklungs Gmbh

patents

4. 1 out of 3

Advantage Therapeutics, Inc.

Years Active: 2006-2021

Loading Chart...

22 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11147873 - Treatment of Alzheimer's Disease (AD) with an aluminum salt (2021-10-19),

2. 11065273 - Treatment and prevention of alzheimer's disease (AD) (2021-07-20),

3. 10646565 - Treatment of alzheimer'S disease (AD) with an aluminum salt (2020-05-12),

4. 10478454 - Treatment of Alzheimer's disease (AD) with aluminum oxyhydroxide (2019-11-19),

5. 10344062 - Method of inhibiting C5a (2019-07-09),

6. 9625459 - Method for diagnosing alzheimer's disease (AD) (2017-04-18),

7. 9457078 - Methods for inhibiting C5a with C5a peptides coupled or fused to a carrier protein (2016-10-04),

8. 9029327 - Vaccine (2015-05-12),

9. 8900564 - Vaccine composition comprising an antigen and a peptide having adjuvant properties (2014-12-02),

10. 8618046 - Treatment of atherosclerosis with cholesterol ester transport protein mimotopes (2013-12-31),

11. 8613931 - Compounds for treating beta-amyloidoses (2013-12-24),

12. 8361476 - Vaccine composition comprising an antigen and a peptide having adjuvant properties (2013-01-29),

13. 8277815 - Pharmaceutical composition comprising an antigen (2012-10-02),

14. 8022180 - Method for preventing and treating Alzheimer's disease (2011-09-20),

15. 7935348 - Combination therapy for the treatment of Alzheimer's disease (2011-05-03),

Title: Innovations in Alzheimer's Disease Treatment by Frank Mattner

Introduction: Frank Mattner, a prolific inventor based in Vienna, Austria, has made significant contributions to the field of medical research, particularly in the treatment of Alzheimer's Disease (AD). With an impressive portfolio of 22 patents, his work showcases the intersection of innovative healthcare solutions and cutting-edge scientific research.

Latest Patents: Among his recent inventions, Frank Mattner has developed a method for the treatment of Alzheimer's Disease utilizing an aluminum salt. This patent discloses a pharmaceutical composition that stimulates the immune response in patients diagnosed with AD or those at risk of developing the disease. Another noteworthy patent focuses on the treatment and prevention of dementias associated with β-amyloid deposition, emphasizing the use of aluminum salts as a potential therapeutic agent for Alzheimer's Disease.

Career Highlights: Throughout his career, Frank Mattner has worked with esteemed companies, such as Affiris AG and Intercell AG, where he applied his expertise in pharmaceuticals and biotechnology to advance research and development for innovative medical treatments.

Collaborations: Frank has collaborated with notable peers, including Walter G. Schmidt and Michael Buschle, contributing to a dynamic team focused on improving health outcomes for individuals affected by Alzheimer's Disease. Their joint efforts reflect a commitment to innovation in the medical field.

Conclusion: Frank Mattner continues to be a leading figure in Alzheimer's Disease research. His innovative patents and collaborations highlight his dedication to finding effective treatments for one of the most challenging neurological disorders, reinforcing the importance of continued research in this critical area of healthcare.

This text is generated by artificial intelligence and may not be accurate.